[The RICO rat (genetically hypercholesteremic): a good model for testing a food substance or a drug specific for a key enzyme of cholesterol metabolism].
The genetically hypercholesterolemic RICO rat: a good model for testing a food substance or a drug specific for a key enzyme involved in cholesterol metabolism? The genetically hypercholesterolemic RICO rat, whose cholesterolemia is situated between 1.3 and 1.5 mg x mL(-1), possibly reaching 2 mg x mL(-1), after the addition of cholesterol to its food, possesses a different lipoprotein spectrum than man, because approximatively 70% of the plasma cholesterol is carried by HDL (28% of which are carried by the light HDL1 subfraction, rich in apolipoproteinE (apoE). The effects of certain substances in food (carbohydrates, cholesterol, allyldisulfide, etc.) or drugs (ethinylestradiol, streptozotocin, statins, inhibitors of ACAT, etc.) on the cholesterolemia of the rat were studied, in relation to certain important parameters of cholesterol metabolism (LDLr, VLDL liver secretion, activities of lipolytic enzymes: LPL, HL, etc.). The increase in a number of LDL receptors (LDLr) in the RICO rat, induced by ethinylestradiol, streptozotocin, etc., provokes an important decrease in the apoE-rich HDL concentration, filtered out by its receptors. This decrease is observed in man for LDL. Simvastatin, which stimulates LDLr in man and not in rat, lowers the level of LDL in man and has no effect on the cholesterolemia of the RICO rat. In rat and man, the concentration of plasma cholesterol is inversely proportional to the rate of cholesterol synthesis in the organism and to its plasma turnover rate. The concentration of cholesterol in the plasma carried by the HDL1 of the rat, is however, proportional to hepatic cholesterogenesis. This fraction is positively correlated to the activity of hepatic lipase (HL) and negatively to the activity of lipoprotein lipase (LPL), released by heparin. These data demonstrate the importance of the liver and lipolytic enzymes in the intraplasmatic hydrolysis of HDL3 (precursors of HDL1), murine particles that can be considered similar to human LDL.
Lutton
C
C
Laboratoire de Physiologie de la nutrition, unité associée, université Paris-Sud-XI/Inra, Orsay, France. claude.lutton@ibaic.u-psud.fr
D000818:Animals; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D002791:Cholesterol, Dietary / Q000494:pharmacology; D004032:Diet; D004040:Dietary Carbohydrates / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D006937:Hypercholesterolemia / Q000201:enzymology / Q000235:genetics*; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D051381:Rats; D011922:Rats, Mutant Strains; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors; D013311:Streptozocin / Q000494:pharmacology
D002791:Cholesterol, Dietary; D004040:Dietary Carbohydrates; D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008075:Lipoproteins, HDL; D004997:Ethinyl Estradiol; D013311:Streptozocin; D002784:Cholesterol; D002785:Sterol O-Acyltransferase